Skip to main content
Top
Published in: Journal of Clinical Immunology 7/2022

Open Access 20-06-2022 | Anxiety | Original Article

Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity

Authors: Bethany Nicholson, Rupert Goodman, James Day, Austen Worth, Ben Carpenter, Kit Sandford, Emma C. Morris, Siobhan O. Burns, Deborah Ridout, Penny Titman, Mari Campbell

Published in: Journal of Clinical Immunology | Issue 7/2022

Login to get access

Abstract

Background

Hematopoietic stem cell transplant (HSCT) is well established as a corrective treatment for many inborn errors of immunity (IEIs) presenting in childhood. Due to improved techniques, more transplants are undertaken and patients are living longer. However, long-term complications can significantly affect future health and quality of life. Previous research has focused on short-term medical outcomes and little is known about health or psychosocial outcomes in adulthood.

Objective

This project aimed to ascertain the long-term social and psychological outcomes for adults who underwent HSCT for IEI during childhood.

Methods

Adult patients, who had all undergone HSCT for IEI during childhood at two specialist immunology services at least 5 years previously, were invited to participate in the study. Questionnaires and practical tasks assessed their current functioning and circumstances. Information was also gathered from medical notes. Data was compared with population norms and a control group of participant-nominated siblings or friends.

Results

Eighty-three patients and 46 matched controls participated in the study. Patients reported significantly better physical health-related quality of life than the general population norm, but significantly worse than matched controls. Patient’s self-reported physical health status and the perceived impact of their physical health on everyday life were worse than matched controls and patients reported higher levels of anxiety and lower mood than the general population. For those where their IEI diagnosis was not associated with a learning disability, cognitive function was generally within the normal range.

Conclusions

Patients who have had a HSCT in childhood report mixed psychosocial outcomes in adulthood. More research is needed to establish screening protocols and targeted interventions to maximize holistic outcomes.

Clinical Implications

Screening for holistic needs and common mental health difficulties should be part of routine follow-up. Information should be provided to patients and families in order to support decision-making regarding progression to transplant and the early identification of any difficulties.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fischer A, Cavazzana-Calvo M, de Saint BG, DeVillartay JP, Di Santo JP, Hivroz C, et al. Naturally occurring primary deficiencies of the immune system. Annual Rev Immunol. 1997;1997(15):93–124.CrossRef Fischer A, Cavazzana-Calvo M, de Saint BG, DeVillartay JP, Di Santo JP, Hivroz C, et al. Naturally occurring primary deficiencies of the immune system. Annual Rev Immunol. 1997;1997(15):93–124.CrossRef
2.
go back to reference Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally though. J Allergy Clin Immunol. 2013;33:1–7. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally though. J Allergy Clin Immunol. 2013;33:1–7.
3.
go back to reference Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020 Jan;40(1):66-81. doi: 10.1007/s10875-020-00758-x. Epub 2020 Feb 11. PMID: 32048120; PMCID: PMC7082388. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020 Jan;40(1):66-81. doi: 10.1007/s10875-020-00758-x. Epub 2020 Feb 11. PMID: 32048120; PMCID: PMC7082388.
5.
go back to reference Passweg JR, Baldomero H, Chabannon C, Basak GW, Corbacioglu S, Duarte R, et al. European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus. Bone Marrow Transplant 2020 Aug;55(8):1604-1613. doi: 10.1038/s41409-020-0826-4. Epub 2020 Feb 17. PMID: 32066864; PMCID: PMC7391287 Passweg JR, Baldomero H, Chabannon C, Basak GW, Corbacioglu S, Duarte R, et al. European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus. Bone Marrow Transplant 2020 Aug;55(8):1604-1613. doi: 10.1038/s41409-020-0826-4. Epub 2020 Feb 17. PMID: 32066864; PMCID: PMC7391287
6.
go back to reference Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fasth A, et al. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. Biol Blood Marrow Transplant. 2012;18(9):1438–45.PubMedPubMedCentralCrossRef Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fasth A, et al. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. Biol Blood Marrow Transplant. 2012;18(9):1438–45.PubMedPubMedCentralCrossRef
7.
go back to reference Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report. Blood. 2017;129(15):2198–201.PubMedCrossRef Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report. Blood. 2017;129(15):2198–201.PubMedCrossRef
8.
go back to reference Dvorak CC, Hassan A, Slatter MA, Hönig M, Lankester AC, Buckley RH, et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol. 2014;134(4):935–43.e15.PubMedPubMedCentralCrossRef Dvorak CC, Hassan A, Slatter MA, Hönig M, Lankester AC, Buckley RH, et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol. 2014;134(4):935–43.e15.PubMedPubMedCentralCrossRef
9.
go back to reference Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132(17):1737–49.PubMedPubMedCentralCrossRef Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132(17):1737–49.PubMedPubMedCentralCrossRef
10.
go back to reference Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 2014;371(5):434–46.PubMedPubMedCentralCrossRef Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 2014;371(5):434–46.PubMedPubMedCentralCrossRef
11.
go back to reference Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, et al. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood. 2014;123(2):281–9.PubMedPubMedCentralCrossRef Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, et al. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood. 2014;123(2):281–9.PubMedPubMedCentralCrossRef
12.
go back to reference Hönig M, Albert MH, Schulz A, Sparber-Sauer M, Schütz C, Belohradsky B, et al. Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Blood. 2007;109(8):3595–602.PubMedCrossRef Hönig M, Albert MH, Schulz A, Sparber-Sauer M, Schütz C, Belohradsky B, et al. Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Blood. 2007;109(8):3595–602.PubMedCrossRef
13.
go back to reference Mazzolari E, Forino C, Guerci S, Imberti L, Lanfranchi A, Porta F, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007;120(4):892–9.PubMedCrossRef Mazzolari E, Forino C, Guerci S, Imberti L, Lanfranchi A, Porta F, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007;120(4):892–9.PubMedCrossRef
14.
go back to reference Patel NC, Chinen J, Rosenbaltt HM, Hanson IC, Brown BS, Paul ME, et al. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. J Allergy Clin Immunol. 2008;122:1185–93.PubMedCrossRef Patel NC, Chinen J, Rosenbaltt HM, Hanson IC, Brown BS, Paul ME, et al. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. J Allergy Clin Immunol. 2008;122:1185–93.PubMedCrossRef
15.
go back to reference Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Bartolomeo PD, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood. 2002;100:4344–50.PubMedCrossRef Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Bartolomeo PD, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood. 2002;100:4344–50.PubMedCrossRef
16.
go back to reference Soncini E, Slatter MA, Jones LBKR, Hughes S, Hodges S, Flood TJ, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronice granulomatous disease with good long-term outcome and growth. Br J Haematology. 2009;145:73–83.CrossRef Soncini E, Slatter MA, Jones LBKR, Hughes S, Hodges S, Flood TJ, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronice granulomatous disease with good long-term outcome and growth. Br J Haematology. 2009;145:73–83.CrossRef
17.
go back to reference Heimall J, Buckley RH, Puck J, Fleisher TA, Gennery AR, Haddad E, et al. Recommendations for screening and management of late effects in patients with severe combined immunodeficiency after allogenic hematopoietic cell transplantation: a consensus statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biol Blood Marrow Transplant. 2017 Aug;23(8):1229-1240. doi: 10.1016/j.bbmt.2017.04.026. Epub 2017 May 4. PMID: 28479164; PMCID: PMC6015789. Heimall J, Buckley RH, Puck J, Fleisher TA, Gennery AR, Haddad E, et al. Recommendations for screening and management of late effects in patients with severe combined immunodeficiency after allogenic hematopoietic cell transplantation: a consensus statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biol Blood Marrow Transplant. 2017 Aug;23(8):1229-1240. doi: 10.1016/j.bbmt.2017.04.026. Epub 2017 May 4. PMID: 28479164; PMCID: PMC6015789.
18.
go back to reference Nelson AS, Vajdic CM, Ashton LJ, Le Marsney RE, Nivison-Smith I, Wilcox L, et al. CAST investigators. Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases. Pediatr Blood Cancer 2017 Jan;64(1):197-202. doi: https://doi.org/10.1002/pbc.26219. Epub 2016 Sep 26. Nelson AS, Vajdic CM, Ashton LJ, Le Marsney RE, Nivison-Smith I, Wilcox L, et al. CAST investigators. Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases. Pediatr Blood Cancer 2017 Jan;64(1):197-202. doi: https://​doi.​org/​10.​1002/​pbc.​26219. Epub 2016 Sep 26.
19.
go back to reference Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF, et al. Health and functional status of long-term survivors of bone marrow transplantation. Ann Inter Med. 1997;126:184–92.CrossRef Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF, et al. Health and functional status of long-term survivors of bone marrow transplantation. Ann Inter Med. 1997;126:184–92.CrossRef
20.
go back to reference Dvorak CC, Cownan MJ, Logan BR, Notarangelo LD, Griffiths LM, Puck JM, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the Primary Immune Deficiency Treatment Consortium Prospective Study 6901. J Clin Immunol. 2013;33:1156–64.PubMedPubMedCentralCrossRef Dvorak CC, Cownan MJ, Logan BR, Notarangelo LD, Griffiths LM, Puck JM, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the Primary Immune Deficiency Treatment Consortium Prospective Study 6901. J Clin Immunol. 2013;33:1156–64.PubMedPubMedCentralCrossRef
21.
go back to reference Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Krance RA, Paul ME, et al. Outcome of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2009;124:1062–9.PubMedPubMedCentralCrossRef Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Krance RA, Paul ME, et al. Outcome of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2009;124:1062–9.PubMedPubMedCentralCrossRef
22.
go back to reference Tewari P, Martin PL, Mendizabal A, Parikh SH, Page KM, Driscoll TA, et al. Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in Chronic Granulomatous Disease. Biol Blood Marrow Transplant. 2012;18:1368–77.PubMedPubMedCentralCrossRef Tewari P, Martin PL, Mendizabal A, Parikh SH, Page KM, Driscoll TA, et al. Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in Chronic Granulomatous Disease. Biol Blood Marrow Transplant. 2012;18:1368–77.PubMedPubMedCentralCrossRef
23.
go back to reference Cole T, McKendrick F, Titman P, Cant AJ, Pearce MS, Cale CM, et al. Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison with those managed conservatively with those that have undergone Haematopoietic Stem Cell Transplant. J Clin Immunol. 2013;33:8–13.PubMedCrossRef Cole T, McKendrick F, Titman P, Cant AJ, Pearce MS, Cale CM, et al. Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison with those managed conservatively with those that have undergone Haematopoietic Stem Cell Transplant. J Clin Immunol. 2013;33:8–13.PubMedCrossRef
24.
go back to reference Nuss SL, Wilson ME. Health-related quality of life following hematopoietic stem cell transplant during childhood. J Pediatr Oncol Nurs. 2007;24:106–15.PubMedCrossRef Nuss SL, Wilson ME. Health-related quality of life following hematopoietic stem cell transplant during childhood. J Pediatr Oncol Nurs. 2007;24:106–15.PubMedCrossRef
25.
go back to reference Sanders JE, Hoffmeister PA, Storer BE, Appelbaum FR, Storb RF, Syrjala KL. The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant. 2010;45:746–54.PubMedCrossRef Sanders JE, Hoffmeister PA, Storer BE, Appelbaum FR, Storb RF, Syrjala KL. The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant. 2010;45:746–54.PubMedCrossRef
26.
go back to reference Skucek E, Butler S, Gaspar HB, Titman P. Social outcome of children treated by haematopoietic cell transplant for congenital immunodeficiency. Bone Marrow Transplant. 2011;46:1314–20.PubMedCrossRef Skucek E, Butler S, Gaspar HB, Titman P. Social outcome of children treated by haematopoietic cell transplant for congenital immunodeficiency. Bone Marrow Transplant. 2011;46:1314–20.PubMedCrossRef
27.
go back to reference Titman P, Pink E, Skucek E, O’Hanlon KCT, Cole TH, Gaspar J, et al. Cognitive and behavioural abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies. Blood. 2008;112:3907–13.PubMedCrossRef Titman P, Pink E, Skucek E, O’Hanlon KCT, Cole TH, Gaspar J, et al. Cognitive and behavioural abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies. Blood. 2008;112:3907–13.PubMedCrossRef
28.
go back to reference Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-term health outcome and quality of life post-HSCT for IL7Ra-, Artemis-, RAG1- and RAG2-deficient severe combined immunodeficiency: a single centre report. J Clin Immunol. 2018;38(6):727–32.PubMedCrossRef Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-term health outcome and quality of life post-HSCT for IL7Ra-, Artemis-, RAG1- and RAG2-deficient severe combined immunodeficiency: a single centre report. J Clin Immunol. 2018;38(6):727–32.PubMedCrossRef
29.
go back to reference Phipps S, Rai S, Leung WH, Lensing S, Dunavant M. Cognitive and academic consequences of stem-cell transplantation in children. J Clin Oncol. 2008;26:2027–33.PubMedCrossRef Phipps S, Rai S, Leung WH, Lensing S, Dunavant M. Cognitive and academic consequences of stem-cell transplantation in children. J Clin Oncol. 2008;26:2027–33.PubMedCrossRef
30.
go back to reference Andrykowski MA, Carpenter JS, Greiner CB, Altmaier EM, Burish TG, Antin JH, et al. Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant. 1997;20:669–79.PubMedCrossRef Andrykowski MA, Carpenter JS, Greiner CB, Altmaier EM, Burish TG, Antin JH, et al. Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant. 1997;20:669–79.PubMedCrossRef
31.
go back to reference Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med. 1995;40:479–90.PubMedCrossRef Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med. 1995;40:479–90.PubMedCrossRef
32.
go back to reference Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T. Quality of life: gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant. 2001;28:503–9.PubMedCrossRef Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T. Quality of life: gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant. 2001;28:503–9.PubMedCrossRef
33.
go back to reference Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers MED, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. J Am Med Assoc. 2004;291:2335–43.CrossRef Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers MED, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. J Am Med Assoc. 2004;291:2335–43.CrossRef
34.
go back to reference Syrjala KL, Langer SL, Abrams JR, Storer B, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596–606.PubMedCrossRef Syrjala KL, Langer SL, Abrams JR, Storer B, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596–606.PubMedCrossRef
35.
go back to reference Kentish R, Mance J. Psychological effects of deafness and hearing impairment. In: Newton VE, editor. Paediatr Audiol Medicine. 2nd ed. London: Wiley; 2008. Kentish R, Mance J. Psychological effects of deafness and hearing impairment. In: Newton VE, editor. Paediatr Audiol Medicine. 2nd ed. London: Wiley; 2008.
36.
go back to reference Moss T, Rosser B. Psychosocial adjustment to visible difference. The Psychologist. 2008;21:492–5. Moss T, Rosser B. Psychosocial adjustment to visible difference. The Psychologist. 2008;21:492–5.
37.
go back to reference Depression in adults with a chronic physical health problem: treatment and management. Natl Inst Health Care Excell. 2009. Depression in adults with a chronic physical health problem: treatment and management. Natl Inst Health Care Excell. 2009.
38.
go back to reference Assessment and treatment for people with fertility problems. National Institute for Health and Care Excellence. 2013. Assessment and treatment for people with fertility problems. National Institute for Health and Care Excellence. 2013.
39.
go back to reference Nyman SR, Gosney MA, Victor CR. Psychosocial impact of visual impairment in working-age adults. Br J Ophthalmology. 2010;94:1427–31.CrossRef Nyman SR, Gosney MA, Victor CR. Psychosocial impact of visual impairment in working-age adults. Br J Ophthalmology. 2010;94:1427–31.CrossRef
40.
go back to reference McAllister M, Davies L, Payne K, Nicholls S, Donnai D, MacLeod R. The emotional effects of genetic diseases: implications for clinical genetics. Am J Med Genetics 2007; Part A; 143A: 2651-2661 McAllister M, Davies L, Payne K, Nicholls S, Donnai D, MacLeod R. The emotional effects of genetic diseases: implications for clinical genetics. Am J Med Genetics 2007; Part A; 143A: 2651-2661
42.
go back to reference Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef
43.
go back to reference Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Medicine. 2006;166:1092–7.CrossRef Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Medicine. 2006;166:1092–7.CrossRef
44.
go back to reference Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Medicine. 2001;16:606–13.CrossRef Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Medicine. 2001;16:606–13.CrossRef
45.
go back to reference Wechsler D. Wechsler Adult Intelligence Scale–Fourth Edition. Pearson; San Antonio, TX. 2008. Wechsler D. Wechsler Adult Intelligence Scale–Fourth Edition. Pearson; San Antonio, TX. 2008.
46.
go back to reference Sheridan CL, Mulhern M, Martin D. Validation of a self-report measure of somatic health. Psychol Rep. 1998;82:697–87.CrossRef Sheridan CL, Mulhern M, Martin D. Validation of a self-report measure of somatic health. Psychol Rep. 1998;82:697–87.CrossRef
47.
go back to reference Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461–4.PubMedCrossRef Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461–4.PubMedCrossRef
48.
go back to reference Ware JE User’s manual for the SF-36v2 Health Survey, Second Edition. 2007; 3-12. Ware JE User’s manual for the SF-36v2 Health Survey, Second Edition. 2007; 3-12.
50.
go back to reference The Improving Access to Psychological Therapies Manual. National Collaborating Centre for Mental Health. 2019. The Improving Access to Psychological Therapies Manual. National Collaborating Centre for Mental Health. 2019.
52.
go back to reference Day JW, Elfeky R, Nicholson B, Goodman R, Pearce R, Fox TA, Worth A, Booth C, Veys P, Carpenter B, Hough R, Gaspar HB, Titman P, Ridout, D, Workman S, Hernandes F. Sandford K, Laurence A, Campbell M, Burns SO, Burns SO, Morris EC (2022) Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood. J Clin Immunol. https://doi.org/10.1007/s10875-022-01278-6 Day JW, Elfeky R, Nicholson B, Goodman R, Pearce R, Fox TA, Worth A, Booth C, Veys P, Carpenter B, Hough R, Gaspar HB, Titman P, Ridout, D, Workman S, Hernandes F. Sandford K, Laurence A, Campbell M, Burns SO, Burns SO, Morris EC (2022) Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood. J Clin Immunol. https://​doi.​org/​10.​1007/​s10875-022-01278-6
53.
go back to reference In the face of fear. Mental Health Foundation. 2009. In the face of fear. Mental Health Foundation. 2009.
54.
go back to reference Booker K, Bansal A, Haeney M, Bansal, Vieira A. Identifying risk for sub-optimal health-related quality of life and adjustment to illness in adults with primary antibody deficiency syndrome (PADS): Summary Report for the PiA 2007. Booker K, Bansal A, Haeney M, Bansal, Vieira A. Identifying risk for sub-optimal health-related quality of life and adjustment to illness in adults with primary antibody deficiency syndrome (PADS): Summary Report for the PiA 2007.
56.
go back to reference Nathan PC, Nachman A, Sutradhar R, et al. Adverse mental health outcomes in a population-based cohort of survivors of childhood cancer. Cancer. 2018;124:2045–57.PubMedCrossRef Nathan PC, Nachman A, Sutradhar R, et al. Adverse mental health outcomes in a population-based cohort of survivors of childhood cancer. Cancer. 2018;124:2045–57.PubMedCrossRef
57.
go back to reference Generalised anxiety disorder and panic disorder in adults: management. Natl Inst Health Care Excell. 2019 Generalised anxiety disorder and panic disorder in adults: management. Natl Inst Health Care Excell. 2019
58.
go back to reference Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factor mortality: a meta-analytic review. Perspect Psychol Sci. 2015;10:227–37.PubMedCrossRef Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factor mortality: a meta-analytic review. Perspect Psychol Sci. 2015;10:227–37.PubMedCrossRef
59.
go back to reference Valtorta NK, Kanaan M, Gilbody S, Ronzi S, Hanratty B. Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies. Heart. 2016 Jul 1;102(13):1009-16. doi: 10.1136/heartjnl-2015-308790. Epub 2016 Apr 18. PMID: 27091846; PMCID: PMC4941172. Valtorta NK, Kanaan M, Gilbody S, Ronzi S, Hanratty B. Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies. Heart. 2016 Jul 1;102(13):1009-16. doi: 10.1136/heartjnl-2015-308790. Epub 2016 Apr 18. PMID: 27091846; PMCID: PMC4941172.
60.
go back to reference Mushtaq R, Shoib S, Shah T, Mushtaq S. Relationship between loneliness, psychiatric disorders and physical health? A review on the psychological aspects of loneliness. J Clin Diagn Res. 2014;8:WE01-04. Mushtaq R, Shoib S, Shah T, Mushtaq S. Relationship between loneliness, psychiatric disorders and physical health? A review on the psychological aspects of loneliness. J Clin Diagn Res. 2014;8:WE01-04.
61.
go back to reference Packman W, Gong K, VanZutphen K, Shaffer T, Crittenden M. Psychosocial adjustment of adolescent siblings of hematopoietic stem cell transplant patients. J Pediatr Oncol Nurs. 2004;21:233–48.PubMedCrossRef Packman W, Gong K, VanZutphen K, Shaffer T, Crittenden M. Psychosocial adjustment of adolescent siblings of hematopoietic stem cell transplant patients. J Pediatr Oncol Nurs. 2004;21:233–48.PubMedCrossRef
Metadata
Title
Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity
Authors
Bethany Nicholson
Rupert Goodman
James Day
Austen Worth
Ben Carpenter
Kit Sandford
Emma C. Morris
Siobhan O. Burns
Deborah Ridout
Penny Titman
Mari Campbell
Publication date
20-06-2022
Publisher
Springer US
Keyword
Anxiety
Published in
Journal of Clinical Immunology / Issue 7/2022
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01286-6

Other articles of this Issue 7/2022

Journal of Clinical Immunology 7/2022 Go to the issue